Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer

British Journal of Cancer

Volumn 90, Issue 12, 2004, Pages 2288-2296

  Di Maio, M ^b   Gridelli, C ^a   Gallo, C ^b   Manzione, L ^b   Brancaccio, L ^b   Barbera, S ^b   Robbiati, S F ^b   Ianniello, G P ^b   Ferrau F ^b   Piazza, E ^b   Frontini, L ^b   Rosetti, F ^b   Carrozza, F ^b   Bearz, A ^b   Spatafora, M ^b   Adamo, V ^b   Isa, L ^b   Iaffaioli, R V ^b   Di Salvo, E ^b   Perrone, F ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b NONE

Author keywords

Analgesics; Cancer pain; Lung cancer; Pain Management Index

Indexed keywords

ACETIC ACID DERIVATIVE; ANALGESIC AGENT; ANILIDE; ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; ANTIPYRETIC AGENT; BUPRENORPHINE; CISPLATIN; CODEINE; DEXTROPROPOXYPHENE; DICLOFENAC; FENTANYL; GEMCITABINE; IBUPROFEN; KETOROLAC; MORPHINE; NAPROXEN; NAVELBINE; NIMESULIDE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; OXICAM DERIVATIVE; PARACETAMOL; PIROXICAM; PROPIONIC ACID DERIVATIVE; SALICYLIC ACID; SALICYLIC ACID DERIVATIVE; TRAMADOL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BONE METASTASIS; CANCER PAIN; CLINICAL PRACTICE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; FEMALE; HUMAN; ITALY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; MULTIVARIATE ANALYSIS; PAIN ASSESSMENT; PHYSICIAN; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; BONE TUMOR; HOSPITALIZATION; LUNG TUMOR; METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PAIN; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; ITALY; LUNG NEOPLASMS; MALE; MIDDLE AGED; PAIN; PAIN MEASUREMENT; PREVALENCE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS; SEVERITY OF ILLNESS INDEX;

EID: 3042696856     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6601810     Document Type: Article

References (40)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365-376
2. American Society of Clinical Oncology (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14: 671-679
3. Beck SL, Falkson G (2001) Prevalence and management of cancer pain in South Africa. Pain 94: 75-84
4. Becker N, Bondegaard Thomsen A, Olsen AK, Sjogren P, Bech P, Eriksen J (1997) Pain epidemiology and health-related quality of life in chronic non-malignant pain patients referred to a Danish multidisciplinary pain center. Pain 73: 393-400
5. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M (1994) The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. Eur J Cancer 30A: 635-642
6. Bernabei R, Gambassi G, Lapane K, Landi F, Gatsonis C, Dunlop R, Lipsitz L, Steel K, Mor V (1998) Management of pain in elderly patients with cancer. SAGE Study Group. Systematic Assessment of Geriatric Drug Use via Epidemiology. JAMA 279: 1877-1882
7. Bonica JJ (1990) Cancer pain. In The Management of Pain, Bonica: JJ (ed) Vol. 1, pp 400-460. Philadelphia: Lea and Febiger
8. Cleary JF (2000) Cancer pain management. Cancer Control 7: 120-131
9. Cleeland CS (1998) Undertreatment of cancer pain in elderly patients. JAMA 279: 1914-1915
10. Cleeland CS, Gonin R, Baez L, Loehrer P, Pandya KJ (1997) Pain and treatment of pain in minority patients with cancer. The Eastern Coopoerative Oncology Group minority outpatient pain study. Ann Intern Med 127: 813-816
11. Cleeland CS, Gonin R, Hatfield AK, Edmonson JH, Blum RH, Stewart JA, Pandya KJ (1994) Pain and its treatment in outpatients with metastatic cancer. N Engl J Med 330: 592-596
12. Coleman RE (1997) Skeletal complications of malignancy. Cancer 80(Suppl): 1588-1594
13. Daut RL, Cleeland CS (1982) The prevalence and severity of pain in cancer. Cancer 50: 1913-1918
14. Detmar SB, Muller MJ, Schornagel JH, Wever LD, Aaronson NK (2002) Health-related quality-of-life assessments and patient - physician communication: a randomized controlled trial. JAMA 288: 3027-3034
15. Di Maio M, Perrone F, Gallo C, Iaffaioli RV, Manzione L, Piantedosi FV, Cigolari S, Illiano A, Barbera S, Robbiati SF, Piazza E, Ianniello GP, Frontini L, Veltri E, Castiglione F, Rosetti F, De Maio E, Maione P, Gridelli C (2003) Supportive care in patients with advanced non-small-cell lung cancer. Br J Cancer 89: 1013-1021
16. Fayers P, Aaronson N, Bjordal K, Sullivan M (1999) EORTC Scoring Manual, 2nd edition Brussels, Belgium: Quality of Life Unit, EORTC Data Centre.
17. Ferrell BR, Dow KH, Grant M (1995) Measurement of the quality of life in cancer survivors. Qual Life Res 4: 523-531
18. Gazzetta Ufficiale della Repubblica Italiana n.41 February 19th (2001) Legge 8 febbraio 2001, n. 12. 'Norme per agevolare l'impiego dei farmaci analgesici oppiacei nella terapia del dolore', 2001 (Italian). http://www.parlamento.it/ parlam/leggi/01012l.htm Accessed December 15th, 2003
19. Ginsberg RJ, Vokes EE, Raben A (1997) Non-small cell lung cancer, clinical features. In Cancer: Principles & Practice of Oncology, DeVita V, Hellman S, Rosenberg SA (eds) pp 866-868. Philadelphia: Lippincott-Raven Publishers
20. Greenwald HP, Bonica JJ, Bergner M (1987) The prevalence of pain in four cancers. Cancer 60: 2563-2569
21. Gridelli C, Gallo C, Shepherd FA, Illiano A, Piantedosi F, Robbiati SF, Manzione L, Barbera S, Frontini L, Veltri E, Findlay B, Cigolari S, Myers R, Ianniello GP, Gebbia V, Gasparini G, Fava S, Hirsh V, Bezjak A, Seymour L, Perrone F (2003b) Gemcitabine plus vinorelbine compared with cisplatin plus vinorelbine or cisplatin plus gemcitabine for advanced non-small-cell lung cancer: a phase III trial of the Italian GEMVIN Investigators and the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 21: 3025-3034
22. Gridelli C, Perrone F, Gallo C, Cigolari S, Rossi A, Piantedosi FV, Barbera S, Ferraù F, Piazza E, Rosetti M, Clerici M, Bertetto O, Robbiati SF, Frontini L, Sacco C, Castiglione F, Favaretto A, Novello S, Migliorino MR, Gasparini G, Galetta D, Iaffaioli RV, Gebbia V for the MILES Investigators (2003a) Chemotherapy for elderly patients with advanced non-small-cell lung cancer: the Multicenter Italian Lung cancer in the Elderly Study (MILES) phase III randomized trial. J Natl Cancer Inst 95: 362-372
23. Jacox A, Carr DB, Payne R (1994) New clinical-practice guidelines for the management of pain in patients with cancer. N Engl J Med 330: 651-655
24. Larue F, Colleau SM, Brasseur L, Cleeland CS (1995) Multicentre study of cancer pain and its treatment in France. Br Med J 310: 1034-1037
25. Mercadante S (2002) Opioid prescription in Italy, new law, no effect. Lancet 360: 1254-1255
26. Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-655
27. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16: 139-144
28. Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543
29. Perrone F, Gallo C, Gridelli C (2002) Re: Cisplatin-based therapy for elderly patients with advanced non-small-cell lung cancer: implications of Eastern Cooperative Oncology Group 5592, a randomized trial. J Natl Cancer Inst 94: 1029-1030
30. The Elderly Lung cancer Vinorelbine Italian Study group (1999) Effects of vinorelbine on quality of life and survival of elderly patients with advanced non small cell lung cancer. J Natl Cancer Inst 91: 66-72
31. Velikova G, Booth L, Smith AB, Brown PM, Lynch P, Brown JM, Selby PJ (2004) Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial. J Clin Oncol 22: 714-724
32. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59: 850-856
33. Von Roenn JH, Cleeland CS, Gonin R, Hatfleld AK, Pandya KJ (1993) Physician attitudes and practice in cancer pain management: a survey from the Eastern Cooperative Oncology Group. Ann Intern Med 119: 121-126
34. Wang XS, Cleeland CS, Mendoza TR, Engstrom MC, Liu S, Xu G, Hao X, Wang Y, Ren XS (1999) The effects of pain severity on health-related quality of life: a study of Chinese cancer patients. Cancer 86: 1848-1855
35. nd edn) Geneva, Switzerland: World Health Organization
36. World Health Organization (2000) Annex 4: global consumption of principal narcotic drugs. In Achieving Balance in National Opioids Control Policy. Guidelines for Assessment. Geneva, Switzerland: World Health Organization
37. World Health Organization Collaborating Centre for Drug Statistics Methodology (2002) Guidelines for ATC Classification and DDD Assignment. Oslo, Norway: World Health Organization
38. Yun YH, Heo DS, Lee IG, Jeong HS, Kim HJ, Kim SY, Kim YH, Ro YJ, Yoon SS, Lee KH, Huh BY (2003) Multicenter study of pain and its management in patients with advanced cancer in Korea. J Pain Symptom Manage 25: 430-437
39. Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization Guidelines for cancer pain relief a 10 year prospective study. Pain 63: 65-76
40. Zenz M, Zenz T, Tryba M, Strumpf M (1995) Severe undertreatment of cancer pain: a 3-year survey of the German situation. J Pain Symptom Manage 10: 187-191